Compare Stocks: HIMS, DGX, LH, and GH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$235.06 -4.0%	$234.59	$171.18 ▼ $248.84	$27.03B	0.55	944,274 shs	2.72 million shs
GH Guardant Health	$177.16 +1.9%	$161.75	$55.38 ▼ $183.51	$23.33B	1.57	1.73 million shs	2.21 million shs
HIMS Hims & Hers Health	$30.47 +3.8%	$29.87	$13.74 ▼ $65.30	$6.85B	2.42	8.69 million shs	16.61 million shs
LH Labcorp	$310.63 -3.2%	$316.10	$244.52 ▼ $341.80	$26.03B	0.88	706,750 shs	1.91 million shs

10 Best Stocks to Own - Fall 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	-3.98%	-4.91%	-3.80%	+15.46%	+27.14%
GH Guardant Health	+1.89%	+0.86%	+3.79%	+29.35%	+196.35%
HIMS Hims & Hers Health	+3.52%	+9.29%	-9.52%	-6.58%	-47.26%
LH Labcorp	-3.31%	-4.00%	-7.56%	+16.86%	+11.29%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$235.06 -4.0%	$234.59	$171.18 ▼ $248.84	$27.03B	0.55	944,274 shs	2.72 million shs
GH Guardant Health	$177.16 +1.9%	$161.75	$55.38 ▼ $183.51	$23.33B	1.57	1.73 million shs	2.21 million shs
HIMS Hims & Hers Health	$30.47 +3.8%	$29.87	$13.74 ▼ $65.30	$6.85B	2.42	8.69 million shs	16.61 million shs
LH Labcorp	$310.63 -3.2%	$316.10	$244.52 ▼ $341.80	$26.03B	0.88	706,750 shs	1.91 million shs

10 Best Stocks to Own - Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	-3.98%	-4.91%	-3.80%	+15.46%	+27.14%
GH Guardant Health	+1.89%	+0.86%	+3.79%	+29.35%	+196.35%
HIMS Hims & Hers Health	+3.52%	+9.29%	-9.52%	-6.58%	-47.26%
LH Labcorp	-3.31%	-4.00%	-7.56%	+16.86%	+11.29%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DGX Quest Diagnostics	2.54	Moderate Buy	$237.08	0.86% Upside
GH Guardant Health	2.96	Moderate Buy	$188.13	6.19% Upside
HIMS Hims & Hers Health	2.13	Hold	$32.43	6.46% Upside
LH Labcorp	2.75	Moderate Buy	$337.73	8.72% Upside

Current Analyst Ratings Breakdown

Latest HIMS, DGX, LH, and GH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/21/2026	DGX Quest Diagnostics	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$250.00 ➝ $260.00
9/21/2026	LH Labcorp	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$350.00 ➝ $365.00
9/15/2026	GH Guardant Health	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight
9/11/2026	LH Labcorp	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$361.00 ➝ $380.00
9/11/2026	LH Labcorp	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$320.00 ➝ $330.00
9/11/2026	HIMS Hims & Hers Health	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$32.00
9/10/2026	GH Guardant Health	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$210.00
9/9/2026	GH Guardant Health	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$175.00 ➝ $225.00
9/8/2026	DGX Quest Diagnostics	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$232.00 ➝ $245.00
9/8/2026	GH Guardant Health	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$203.00
9/8/2026	GH Guardant Health	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$203.00

(Data available from 9/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DGX Quest Diagnostics	$11.04B	2.35	$14.56 per share	16.14	$64.78 per share	3.63
GH Guardant Health	$982.02M	24.21	N/A	N/A	($0.79) per share	-224.25
HIMS Hims & Hers Health	$2.35B	3.03	$0.87 per share	35.07	$2.38 per share	12.80
LH Labcorp	$13.95B	1.81	$24.02 per share	12.93	$103.98 per share	2.99

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DGX Quest Diagnostics	$992M	$9.42	24.95	19.64	2.24	9.18%	16.01%	7.27%	10/20/2026 (Estimated)
GH Guardant Health	-$416.28M	-$3.49	N/A	N/A	N/A	-38.33%	N/A	-25.40%	10/28/2026 (Estimated)
HIMS Hims & Hers Health	$128.37M	-$0.63	N/A	69.24	N/A	-5.51%	-6.51%	-1.20%	11/9/2026 (Estimated)
LH Labcorp	$876.50M	$12.09	25.69	15.77	1.82	6.99%	16.74%	7.81%	10/27/2026 (Estimated)

Latest HIMS, DGX, LH, and GH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
10/20/2026	Q3 2026	DGX Quest Diagnostics	$2.85	N/A	N/A	N/A	$3.04 billion	N/A
8/10/2026	Q2 2026	HIMS Hims & Hers Health	-$0.0498	-$0.37	-$0.3202	-$0.37	$698.90 million	$753.21 million
7/30/2026	Q2 2026	GH Guardant Health	-$0.7618	-$0.42	+$0.3418	-$0.90	$314.23 million	$334.98 million
7/30/2026	Q2 2026	LH Labcorp	$4.78	$4.99	+$0.21	$3.64	$3.71 billion	$3.73 billion
7/23/2026	Q2 2026	DGX Quest Diagnostics	$2.82	$3.12	+$0.30	$2.84	$2.97 billion	$3.04 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DGX Quest Diagnostics	$3.44	1.46%	+7.34%	36.52%	14 Years
GH Guardant Health	N/A	N/A	N/A	N/A	N/A
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
LH Labcorp	$2.88	0.93%	N/A	23.82%	N/A

Latest HIMS, DGX, LH, and GH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/12/2026	DGX Quest Diagnostics	quarterly	$0.86	1.45%	10/6/2026	10/6/2026	10/21/2026
7/9/2026	LH Labcorp	quarterly	$0.72	0.86%	8/28/2026	8/28/2026	9/11/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DGX Quest Diagnostics	0.72	1.59	1.46
GH Guardant Health	N/A	4.03	3.71
HIMS Hims & Hers Health	4.21	0.93	0.87
LH Labcorp	0.69	1.80	1.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DGX Quest Diagnostics	88.06%
GH Guardant Health	92.60%
HIMS Hims & Hers Health	63.52%
LH Labcorp	95.94%

Insider Ownership

Company	Insider Ownership
DGX Quest Diagnostics	0.88%
GH Guardant Health	5.60%
HIMS Hims & Hers Health	11.76%
LH Labcorp	0.84%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DGX Quest Diagnostics	57,000	110.37 million	109.40 million	Optionable
GH Guardant Health	2,506	134.20 million	126.68 million	Not Optionable
HIMS Hims & Hers Health	2,442	233.31 million	205.88 million	Optionable
LH Labcorp	71,000	81.10 million	80.42 million	Optionable

HIMS, DGX, LH, and GH Headlines

Recent News About These Companies

Labcorp stock falls 2.94 percent ahead of the open

1 hour ago | ad-hoc-news.deA

Labcorp Reaffirms Long-Term Earnings Outlook

September 22 at 8:36 PM | finance.yahoo.com

Labcorp Holdings Inc. stock underperforms Tuesday when compared to competitors

September 22 at 8:36 PM | marketwatch.com

Labcorp's Future Driven By Clinical Testing Demand, Despite Impact From Medicare Cuts

September 22 at 7:00 PM | seekingalpha.com

Labcorp (NYSE:LH) Shares Gap Down - Time to Sell?

September 22 at 10:59 AM | marketbeat.com

Baird Adjusts Price Target on Labcorp Holdings to $361 From $352, Maintains Outperform Rating

September 22 at 9:17 AM | marketscreener.comM

Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services

September 22 at 9:17 AM | finance.yahoo.com

Labcorp stock heads into the open after a 0.1 percent gain

September 22 at 4:17 AM | ad-hoc-news.deA

Nykredit A S Buys Shares of 23,785 Labcorp Holdings Inc. $LH

September 22 at 3:20 AM | marketbeat.com

Truist Financial Issues Positive Forecast for Labcorp (NYSE:LH) Stock Price

September 22 at 1:54 AM | americanbankingnews.com

Labcorp (NYSE:LH) Stock Price Expected to Rise, Truist Financial Analyst Says

September 21 at 9:17 AM | marketbeat.com

Labcorp stock holds near recent highs after Q2 2026 earnings beat

September 21 at 7:33 AM | ad-hoc-news.deA

Truist Lifts Price Target on Labcorp Holdings to $365 From $350, Keeps Buy Rating

September 21 at 7:33 AM | marketscreener.comM

Labcorp (NYSE:LH) Issues FY 2026 Earnings Guidance

September 20 at 7:11 AM | americanbankingnews.com

Labcorp (NYSE:LH) Updates FY 2026 Earnings Guidance

September 18, 2026 | marketbeat.com

Baird Financial Group Inc. Purchases 5,966 Shares of Labcorp Holdings Inc. $LH

September 17, 2026 | marketbeat.com

Labcorp Holdings Inc. (LH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

September 15, 2026 | seekingalpha.com

Labcorp Holdings Inc. $LH Shares Purchased by Tidal Investments LLC

September 13, 2026 | marketbeat.com

National Pension Service Sells 146,486 Shares of Labcorp Holdings Inc. $LH

September 13, 2026 | marketbeat.com

Labcorp (NYSE:LH) & Surgery Partners (NASDAQ:SGRY) Financial Review

September 13, 2026 | americanbankingnews.com

Labcorp Holdings Inc. (LH) Analyst/Investor Day - Slideshow

September 12, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

HIMS, DGX, LH, and GH Company Descriptions

Quest Diagnostics NYSE:DGX

$235.06 -9.83 (-4.01%)

Closing price 09/22/2026 03:59 PM Eastern

Extended Trading

$236.38 +1.32 (+0.56%)

As of 09/22/2026 07:45 PM Eastern

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Guardant Health NASDAQ:GH

$177.16 +3.29 (+1.89%)

Closing price 09/22/2026 04:00 PM Eastern

Extended Trading

$181.08 +3.93 (+2.22%)

As of 09/22/2026 07:30 PM Eastern

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Hims & Hers Health NYSE:HIMS

$30.47 +1.12 (+3.80%)

Closing price 09/22/2026 03:59 PM Eastern

Extended Trading

$30.44 -0.03 (-0.10%)

As of 09/22/2026 07:59 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Labcorp NYSE:LH

$310.63 -10.36 (-3.23%)

Closing price 09/22/2026 03:59 PM Eastern

Extended Trading

$311.21 +0.58 (+0.19%)

As of 09/22/2026 07:55 PM Eastern

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIMS, DGX, LH, and GH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIMS, DGX, LH, and GH Earnings

Compare Dividends

Latest HIMS, DGX, LH, and GH Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIMS, DGX, LH, and GH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIMS, DGX, LH, and GH Company Descriptions

Quest Diagnostics NYSE:DGX

Guardant Health NASDAQ:GH

Hims & Hers Health NYSE:HIMS

Labcorp NYSE:LH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools